- ALXN has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $477.4 million.
- ALXN has traded 553,469 shares today.
- ALXN is up 3.2% today.
- ALXN was down 8% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in ALXN with the Ticky from Trade-Ideas. See the FREE profile for ALXN NOW at Trade-Ideas More details on ALXN: Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. ALXN has a PE ratio of 57.7. Currently there are 15 analysts that rate Alexion Pharmaceuticals a buy, no analysts rate it a sell, and 1 rates it a hold. The average volume for Alexion Pharmaceuticals has been 1.2 million shares per day over the past 30 days. Alexion has a market cap of $33.6 billion and is part of the health care sector and drugs industry. The stock has a beta of 1.18 and a short float of 2.6% with 1.10 days to cover. Shares are down 8.9% year-to-date as of the close of trading on Wednesday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.